Zhang, Cuifang
Li, Tianqi
Yin, Shuyao
Gao, Mingyi
He, Helen
Li, Ying http://orcid.org/0000-0003-4080-3214
Jiang, Dong
Shi, Minghui
Wang, Jianbin http://orcid.org/0000-0001-6725-7925
Funding for this research was provided by:
Ministry of Science and Technology of the People’s Republic of China (2017YFA0503404, 2017YFA0503404, 2017YFA0503404)
National Natural Science Foundation of China (31790401, 92054301, 32030023, 31790401, 92054301, 32030023, 31790401, 92054301, 32030023)
Beijing Municipal Science and Technology Commission (Z201100005320019, Z201100005320019, Z211100003321002, Z201100005320019,Z211100003321002)
Article History
Received: 24 August 2021
Accepted: 12 October 2022
First Online: 28 November 2022
Competing interests
: L.Y. is the scientific founder of Migrasome therapeutics Ltd. All other authors declare no conflicts of interest.